This undated image provided by Supernus Pharmaceuticals in April 2021 shows bottles for different dosages of the drug Qelbree. On Friday, April 2, 2021, the U.S. Food and Drug Administration approved the medication for treating attention deficit hyperactivity disorder in children ages six through 17. (Supernus Pharmaceuticals via AP) health
FDA OKs first new ADHD drug in over a decade for children Today 05:47 am JST Today | 06:48 am JST WASHINGTON
U.S. regulators have approved the first new drug in over a decade for children with ADHD, which causes inattention, hyperactivity and impulsivity.
The Food and Drug Administration OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily.
She tested negative for COVID-19 so why did her debilitating symptoms linger for months?
Updated 10:29 AM;
Kristin Novotny once led an active life, with regular CrossFit workouts and football in the front yard with her children plus a job managing the kitchen at a middle school. Now, the 33-year-old mother of two from De Pere, Wisconsin, has to rest after any activity, even showering. Conversations leave her short of breath.
Long after their initial coronavirus infections, patients with a malady known as “long COVID-19” continue to struggle with varied symptoms such as fatigue, shortness of breath, gastrointestinal problems, muscle and joint pain, and neurological issues. Novotny has been contending with these and more, despite testing negative for COVID-19-19 seven months ago.
They tested negative for Covid Still, they have long Covid symptoms news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
JMP Group Appoints Investment Expert Alfredo Barreto To Oversee Its Investment Banking Division
JMP Group LLC (NYSE:JMP) said Tuesday that Alfredo Barreto, Jr. has joined the company to serve as a managing director in its investment banking group.
Barreto agreed to advise corporate clients within the cannabis industry.
He is an experienced investment banker with knowledge in consumer and specialty retail.
“His transactional background and industry relationships will make him a key advisor to entrepreneurs and executives seeking differentiated strategic advice and top-tier execution capabilities as they build, finance, and monetize cannabis and cannabis-adjacent businesses in a rapidly changing marketplace,” Mark Lehmann, JMP Group’s president, said.
email article
Cervical excision after prior supracervical hysterectomy led to a high complication rate, particularly bleeding, according to a retrospective review of more than 1,000 cases.
Complications occurred in 38% of the procedures, including bleeding in 26% and gastrointestinal complications in 8%. Additionally, 15% of patients required transfusions. More than a third of the procedures were for leiomyomas, and almost 20% involved malignancies, including cervical cancer. The risks reported here exceed the expected complication rates of total laparoscopic or abdominal hysterectomy, with more than one third of women experiencing any complication, Stephanie L. Wethington, MD, of Johns Hopkins School of Medicine in Baltimore, and co-authors reported in